Washington Post The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a prescription will be able to order online starting next year.
Health experts say the convenience of the spray — FluMist — could lead to increased flu vaccination rates.
The maker of the vaccine, AstraZeneca, said it will supply the vaccine to a third-party online pharmacy where people can complete a screening assessment to determine if they are candidates. The pharmacy will then evaluate patients’ eligibility and decide if they are able to administer the vaccine.
Fair Use Notice
UNMC Global Center for Health Security staff curate publicly available news and information for educational and informational purposes. Brief excerpts of published articles may be displayed under principles of Fair Use, with credit and links provided to the source publications. All copyrights remain the property of their respective owners.